Latest Investor Confidence News

iTech Minerals has confirmed it will soon announce new high-grade antimony findings at its Reynold Range Project, following a notable uptick in its share price and trading volume.

Star Minerals Limited will have its trading suspension lifted on 19 August 2025 following the release of important assay results and its response to an ASX Price Query.

Star Minerals Limited addresses a sharp rise in its share price and trading volume, attributing the movement to pending assay results from recent drilling activities. The company confirms compliance with ASX disclosure rules while preparing to release interpreted data.

Opthea has successfully settled its Development Funding Agreement, avoiding a potential $680 million liability and securing $20 million in cash. Leadership changes include the CEO and CFO stepping down, with the Chairman assuming CEO duties.

MyState Limited has announced a fully franked ordinary dividend of AUD 0.11 per share for the half-year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 1.5% discount.

Kaili Resources addresses ASX price query following a dramatic surge in its share price and trading volume, attributing the movement to its recent rare earth element drilling approval in South Australia.

Lake Resources N.L. has had its trading suspension lifted following the release of a capital raising announcement, signaling renewed market activity for the lithium explorer.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Kaili Resources has addressed a sharp spike in its share price and trading volume, attributing the market interest to its recent approval for rare earth element drilling in South Australia, while confirming no undisclosed material information.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Orion Minerals has successfully closed a Share Purchase Plan raising nearly A$2 million, reinforcing its financial footing as it accelerates towards production. The strong backing from South African shareholders highlights growing investor confidence.